Treatment failure of low molecular weight heparin bridging therapy

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages

  Dattilo, G ^a,b   Lamari, A ^a   Di Bella, G ^b   Scarano, M ^a   De Luca, E ^a   Mutone, D ^a   Busacca, P ^a   Coglitore, S ^b  

^a UO of UTIC and Cardiology Hospital of Urbino   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Atrial fibrillation Thrombosis prevention Low molecular weight heparin Oral anticoagulant therapy

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGED; BICUSPID AORTIC VALVE; CARDIOVASCULAR RISK; CASE REPORT; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS RHYTHM; THROMBOSIS; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE;

ATRIAL FIBRILLATION; LOW-MOLECULAR-WEIGHT HEPARIN; ORAL ANTICOAGULANT THERAPY; THROMBOSIS PREVENTION;

AGED; ANTICOAGULANTS; HEART DISEASES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; THROMBOSIS; TREATMENT FAILURE;

EID: 84881478215     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.183     Document Type: Article

References (35)

1. J.M. Hendriks, H.J. Crijns, R.G. Tieleman, and H.J. Vrijhoef The atrial fibrillation knowledge scale: development, validation and results Int J Cardiol Jan 8 2013 10.1016/j.ijcard.2012.12.047
2. S. Patanè Prostate-specific antigen kallikrein, non-ST elevation myocardial infarction and a new-onset atrial fibrillation in hypertensive patients Int J Cardiol 167 1 2013 283 284
3. T.F. Chao, C.J. Liu, and S.J. Chen CHADS(2) score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan Int J Cardiol Dec 29 2012 10.1016/j.ijcard.2012.12.011
4. S. Patanè, and F. Marte Prostate-specific antigen levels in hypertensive patients suffering from a non-ST elevation myocardial infarction or a new-onset atrial fibrillation Int J Cardiol 158 3 2012 380 382
5. S. Yoshino, A. Yoshikawa, and S. Hamasaki Atrial fibrillation-induced endothelial dysfunction improves after restoration of sinus rhythm Int J Cardiol Dec 23 2012 10.1016/j.ijcard.2012.12.006
6. S. Patanè, M. Sturiale, F. Marte, C. Rizzo, and S. Buonamonte Right bundle branch block with changing axis at the end of atrial fibrillation Int J Cardiol 157 1 May 17 2012 e1 e2
7. S. Patanè, F. Marte, and M. Sturiale Revelation of changing axis deviation at the end of atrial fibrillation without acute myocardial infarction Int J Cardiol 155 2 Mar 8 2012 e19 e21
8. S. John, J. Salmas, and J. Kornej Effects of dronedarone and amiodarone on atrial fibrillatory rate in patients with persistent atrial fibrillation Int J Cardiol Nov 23 2012 10.1016/j.ijcard.2012.11.042
9. S. Patanè, F. Marte, and M. Sturiale Revelation of changing axis deviation at the end of atrial fibrillation associated with endogenous subclinical hyperthyroidism Int J Cardiol 155 1 Feb 23 2012 e1 e4
10. A.M. Salam, H.A. Albinali, and A.W. Al-Mulla Women hospitalized with atrial fibrillation: gender differences, trends and outcome from a 20-year registry in a middle eastern country (1991-2010) Int J Cardiol Nov 15 2012 10.1016/j.ijcard.2012.10.041
11. R. Casado-Arroyo, G.B. Chierchia, and M. Rodriguez-Mañero Atrial fibrillation outcomes: changing the paradigm Int J Cardiol 166 2 2013 545 547
12. S. Patanè, F. Marte, G. Dattilo, and M. Sturiale Changing axis deviation during atrial fibrillation Int J Cardiol 154 1 Jan 12 2012 e1 e3
13. J. Wu, J. Wang, and S. Jiang The efficacy and safety of low intensity warfarin therapy in Chinese elderly atrial fibrillation patients with high CHADS(2) risk score Int J Cardiol Nov 28 2012 10.1016/j.ijcard.2012.11.078
14. S. Patanè, and F. Marte Atrial fibrillation associated with exogenous subclinical hyperthyroidism, changing axis deviation, troponin-I positive and without acute coronary syndrome Int J Cardiol 150 3 Aug 4 2011 e85 e88
15. T.F. Chao, C.J. Liu, and S.J. Chen The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: a nationwide case-control study Int J Cardiol Oct 6 2012 10.1016/j.ijcard.2012.09.058
16. S. Patanè Cardiovascular system and endogenous subclinical hyperthyroidism treatment: the time has come Int J Cardiol 158 2 Jul 12 2012 317 319
17. M. Ozaydin, D. Erdogan, and H. Yucel N-acetyl cysteine for the conversion of atrial fibrillation into sinus rhythm after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled pilot study Int J Cardiol 165 3 2013 580 583
18. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 10 Oct 2012 1385 1413
19. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 21 Nov 2012 2719 2747
20. S. Patanè, F. Marte, and M. Sturiale Acute myocardial infarction without significant coronary stenoses associated with endogenous subclinical hyperthyroidism Int J Cardiol 156 1 Apr 5 2012 e1 e3
21. S. Patanè, F. Marte, and M. Sturiale Endogenous subclinical hyperthyroidism and cardiovascular system: time to reconsider Int J Cardiol 149 1 May 19 2011 108 109
22. Y. Guo, R. Pisters, and S. Apostolakis Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact? Int J Cardiol Oct 23 2012 10.1016/j.ijcard.2012.09.187
23. F. Zannad, W.G. Stough, and V. Regnault Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges Int J Cardiol Jan 5 2013 10.1016/j.ijcard.2012.12.018
24. A.A. Gooshah Gir, H. Namdar, and E. Emaratkar Avicenna's viewon the prevention of thrombosis Int J Cardiol 166 1 2013 274 275
25. S. Patanè, and F. Marte A large left ventricular thrombus Int J Cardiol 135 2 Jun 26 2009 e44 e46
26. S. Patanè, F. Marte, G. Di Bella, and S. Coglitore A large left atrial thrombus mimicking an atrial tumour Int J Cardiol 133 2 Apr 3 2009 e58 e59
27. G. Dattilo, D. Tulino, A. Lamari, V. Tulino, F. Marte, and S. Patanè Treatment failure of low molecular weight heparin in a patient with an aortic mechanical prosthesis Int J Cardiol 146 2 Jan 21 2011 e30 e32
28. S. Buchholz, D. Robaei, N.H. Jacobs, M. O'Rourke, and M.P. Feneley Thromboembolic stroke with concurrent left atrial appendage and left atrial septal pouch thrombus Int J Cardiol 162 1 Dec 15 2012 e16 e17
29. D.Y. Zhang, J. Lozier, and R. Chang Case study and review: treatment of tricuspid prosthetic valve thrombosis Int J Cardiol 162 1 Dec 15 2012 14 19
30. S. Patanè, F. Marte, and G. Risica Treatment failure of low molecular weight heparin bridging therapy before a cardiac surgery intervention in a patient with atrial fibrillation Int J Cardiol 137 3 Nov 12 2009 e59 e60
31. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, and A.J. Camm ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 10 Oct 2010 1360 1420 No abstract available. Erratum in: Europace 13 7 Jul 2011 1058 [Dosage error in article text]
32. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, and A.J. Camm Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 Oct 2010 2369 2429 Erratum in: Eur Heart J 32 9 May 2011 1172
33. D. Poldermans, J.J. Bax, and E. Boersma Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA) Eur J Anaesthesiol 27 2 Feb 2010 92 137
34. D. Poldermans, J.J. Bax, and E. Boersma Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery; European Society of Cardiology (ESC) Eur Heart J 30 22 Nov 2009 2769 2812
35. G. Dattilo, A. Lamari, and V. Tulino Congenital valvular heart disease with high familial penetrance Recenti Prog Med 103 12 Dec 2012